Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GHRS
stocks logo

GHRS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
--
--
-0.274
+61.35%
--
--
-0.297
+56.14%
--
--
-0.303
+102.22%
Estimates Revision
The market is revising No Change the revenue expectations for GH Research PLC (GHRS) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 8.94%.
EPS Estimates for FY2025
Revise Upward
up Image
+0.34%
In Past 3 Month
Stock Price
Go Up
up Image
+8.94%
In Past 3 Month
Wall Street analysts forecast GHRS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GHRS is 28.60 USD with a low forecast of 19.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast GHRS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GHRS is 28.60 USD with a low forecast of 19.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
0 Hold
0 Sell
Strong Buy
Current: 15.350
sliders
Low
19.00
Averages
28.60
High
35.00
Current: 15.350
sliders
Low
19.00
Averages
28.60
High
35.00
Cantor Fitzgerald
initiated
$25
2025-06-04
Reason
Cantor Fitzgerald
Price Target
$25
2025-06-04
initiated
Reason
Guggenheim
Eddie Hickman
Strong Buy
Initiates
$32
2025-03-13
Reason
Guggenheim
Eddie Hickman
Price Target
$32
2025-03-13
Initiates
Strong Buy
Reason
Guggenheim analyst Eddie Hickman initiated coverage of GH Research with a Buy rating and $32 price target.
RBC Capital
Brian Abrahams
Buy
Initiates
$31
2025-03-07
Reason
RBC Capital
Brian Abrahams
Price Target
$31
2025-03-07
Initiates
Buy
Reason
Stifel
Paul Matteis
Strong Buy
Maintains
$18 → $32
2025-02-27
Reason
Stifel
Paul Matteis
Price Target
$18 → $32
2025-02-27
Maintains
Strong Buy
Reason
Cantor Fitzgerald
Charles Duncan
Buy
Initiates
$14
2025-02-13
Reason
Cantor Fitzgerald
Charles Duncan
Price Target
$14
2025-02-13
Initiates
Buy
Reason
HC Wainwright & Co.
Patrick Trucchio
Strong Buy
Reiterates
$40
2025-01-13
Reason
HC Wainwright & Co.
Patrick Trucchio
Price Target
$40
2025-01-13
Reiterates
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for GH Research PLC (GHRS.O) is -12.50, compared to its 5-year average forward P/E of -19.34. For a more detailed relative valuation and DCF analysis to assess GH Research PLC 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-19.34
Current PE
-12.50
Overvalued PE
-3.52
Undervalued PE
-35.16

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-8.67
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
-3.06
Undervalued EV/EBITDA
-14.28

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 735.47% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

GHRS News & Events

Events Timeline

(ET)
2025-11-06
07:09:07
GH Research Announces Q3 EPS of 23 Cents, Matching Consensus Estimates
select
2025-08-07 (ET)
2025-08-07
07:21:17
GH Research reports Q2 EPS (15c), consensus (20c)
select
2025-07-23 (ET)
2025-07-23
08:20:28
GH Research announces program plans, development updates
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.0
10-13Benzinga
Needham Begins Coverage of GH Research with a Buy Rating and Sets Price Target at $19

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make timely decisions in the stock market.

  • Community and Exclusivity: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.

[object Object]
Preview
1.0
10-09Newsfilter
GH Research to Present Innovative Therapies at the 2025 ECNP Congress Symposium and Poster Session

  • Presentation at ECNP Congress: GH Research PLC announced the acceptance of a presentation and two posters at the 38th Annual European College of Neuropsychopharmacology Congress, focusing on long-term clinical data for their treatment GH001 in patients with treatment-resistant depression (TRD).

  • Safety and Efficacy Findings: The open-label extension of the Phase 2b trial for GH001 demonstrated a favorable safety and tolerability profile, with no serious adverse events reported, reinforcing its potential as a rapid-acting treatment option for TRD.

[object Object]
Preview
4.0
07-28TipRanks
3 Best Stocks to Buy Now, 7/28/2025, According to Top Analysts

  • Top Stock Picks: Analysts recommend Schlumberger, DraftKings, and GH Research as strong buy stocks, with significant upside potential based on recent ratings and price targets.

  • Analyst Performance: TipRanks highlights the success of top analysts who have consistently provided accurate ratings, contributing to their five-star ranking status.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is GH Research PLC (GHRS) stock price today?

The current price of GHRS is 15.35 USD — it has increased 6.75 % in the last trading day.

arrow icon

What is GH Research PLC (GHRS)'s business?

GH Research PLC is a clinical-stage biopharmaceutical company. The Company is engaged in offering treatment for psychiatric and neurological disorders. The Company's pipeline includes GH001, GH002 and GH003. The Company focuses on developing its 5- Methoxy-N, N-Dimethyltryptamine, (5-MeO-DMT), therapies for the treatment of patients with Treatment Resistant Depression (TRD). Its product candidate, GH001, is formulated for 5-MeO-DMT administration via an inhalation approach. With GH001, the Company has completed two Phase 1 healthy volunteer clinical trials and a Phase 1/2 clinical trial in patients with treatment-resistant depression (TRD). The GH002 is a 5-MeO-DMT product candidate formulated for administration via an injectable approach. GH002 has completed pre-clinical development to support early clinical trials. The GH003 is a 5-MeO-DMT product candidate formulated for administration via an intranasal administration approach.

arrow icon

What is the price predicton of GHRS Stock?

Wall Street analysts forecast GHRS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GHRS is 28.60 USD with a low forecast of 19.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is GH Research PLC (GHRS)'s revenue for the last quarter?

GH Research PLC revenue for the last quarter amounts to -16.54M USD, increased 30.99 % YoY.

arrow icon

What is GH Research PLC (GHRS)'s earnings per share (EPS) for the last quarter?

GH Research PLC. EPS for the last quarter amounts to -13721000.00 USD, increased 11.45 % YoY.

arrow icon

What changes have occurred in the market's expectations for GH Research PLC (GHRS)'s fundamentals?

The market is revising No Change the revenue expectations for GH Research PLC (GHRS) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 8.94%.
arrow icon

How many employees does GH Research PLC (GHRS). have?

GH Research PLC (GHRS) has 50 emplpoyees as of December 05 2025.

arrow icon

What is GH Research PLC (GHRS) market cap?

Today GHRS has the market capitalization of 953.35M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free